Sonoma Pharmaceuticals Forum: Community User: Moma

Es geht jetzt schon im Pre Market runter

Hab jetzt mein ek wieder. Warten bis 15:30 oder sofort raus, wieder ins minus will ich nicht 🤔

@Texx wieviel Gewinn hat Sonoma gemeldet?

Die Amis werden es wohl wieder runterdrücken, aber ich bin noch weit weg von meinem Einstandskurs...

@markoll sonoma vor 0

16% plus. Wie sieht es nach 15:00 aus?

Korrektur um 752k ist sehr ärgerlich. Erwartet Montag nicht zu viel von den Zahlen. Je höher die Erwartungen, um so größer die Enttäuschung. Amen😇

Betriebskosten um weitere 33% abgesenkt. Break even rückt näher.

Revenues of $5.8 and $11.5 million increased by 22% for the quarter and 25% for the six months ended September 30, 2020 due to strong international growth Operating Expenses continue to trend down by 33% for second quarter 2021 versus second quarter 2020 Net income per share of $0.07 (diluted) from continuing operations for the quarter WOODSTOCK, Ga.--(BUSINESS WIRE)-- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2020. It further announced that it had to restate its first quarter financial statements for the quarter ended June 30, 2020 due to material errors. “We are pleased that our second fiscal quarter results show continued progress towards our goal of building a sustainable company that can deliver both growth and profitability,” said Amy Trombly, CEO of Sonoma Pharmaceuticals. Ms. Trombly continued, “We continue to invest in growth opportunities by building our pipeline of products and working with our extensive network of distributors to commercialize them.” Ms. Trombly continued, “we are disappointed that a first quarter restatement was necessary. At the time the first quarter 10-Q was prepared, we were transitioning offices and staff. The restructuring of our Finance Department is now complete and we have hired a permanent CFO, CPA-certified controller and additional accounting staff to replace the temporary staff. They have been working exceptionally hard in the past few weeks to correct our first quarter 10-Q and prepare our second quarter 10-Q. We expect to be back on track with accurate SEC reporting going forward.” During the review of Sonoma’s financial statements, our staff discovered material errors in the first quarter financial statements that led to a restatement of the quarter ended June 30, 2020. The combined errors led to a correction of net income from $992,000 to $240,000 and earnings per share of $0.54 per share to $0.13 per share.

At the time the first quarter 10-Q was prepared, we were transitioning offices and staff. The restructuring of our Finance Department is now complete and we have hired a permanent CFO, CPA-certified controller and additional accounting staff to replace the temporary staff. Fehler sollte also nie wieder passieren

Gestriger zweiter Peak höher als der erste. Höheres Hoch immer nice. Schönes Wochenende

Aber vermutlich nicht wegen der Zahlen. Die haben ganz andere Pfeile im Köcher.

Angsthasen wieder am Tief raus. Vermutlich mit Verlust. @grinch bin ganz bei dir. Snoa muss / wird viel höher peaken.

Verkauft ruhig. Ich bekomme eure Aktien günstiger 👍😁

Bis dann

Schönes weekend